問卷
此案目前為暫存狀態
編修至YYYY/MM/DD
不開放編輯功能
Find Division/Department
Find Hospital
All Location
All Division/Department
篩選
Developmental Phase
Phase I
Phase I/II
Phase II
Phase II/III
Phase III
Phase IV
Others
Trial Status
Not yet recruiting
Active
Completed
Recruitment Status
Recruiting
Terminated
Stop recruiting
Suspended
Study ended
Trial scale
Multi-Regional Multi-Center
Taiwan Multiple Center
Taiwan Single Center
The expected start time interval of the test
Trial Applicant
Hospital/Foundation
Pharmaceutical/Biopharmaceutical company
Contract Research Organization
Important Roles
Asia Regional PI
Taiwan National PI
Chairman/Global PI
Steering Committee
Advisory board
None
Audit by Sponsors/CRO
Sponsors
CRO
Investigator-initiated trial(IIT)
Yes
Filters
邱泰然
下載
2021-11-01 - 2026-08-02
Condition/Disease
Test Drug
Participate Sites3Sites
Recruiting3Sites
2023-11-01 - 2028-12-31
Participate Sites8Sites
Recruiting8Sites
2020-05-18 - 2023-12-31
Participate Sites6Sites
Recruiting6Sites
2020-08-14 - 2027-07-24
Participate Sites7Sites
Recruiting7Sites
2022-09-01 - 2024-07-15
2025-02-03 - 2029-01-31
Participate Sites5Sites
Recruiting5Sites
2025-06-30 - 2032-05-01
2020-01-31 - 2023-10-03
PD-L1 Positive Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma
GSK3359609
2019-11-01 - 2023-01-31
Biliary Tract Cancer
Bintrafusp alfa (M7824)
2018-03-01 - 2021-01-04
Previously Treated Unresectable Hepatocellular Carcinoma
BGB-A317
Terminated1Sites
Division of General Internal Medicine
Division of Hematology & Oncology
全部
